Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hedrin Dev 42 versus Hedrin 4% lotion for head louse eggs
ISRCTN10431107Phase 3Completed
- Sponsor
- Thornton & Ross
- Start
- Apr 2008
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
Phase 3, open-label trial of dimeticone and Hedrin Dev 42 in pediculosis capitis (2 arms), sponsored by Thornton & Ross. Primary endpoints: Inhibition of egg hatching and Eradication of head lice. Started Apr 2008; status: completed.
02
Drugs
dimeticoneHedrin Dev 42
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on ISRCTN10431107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10431107.